AMERIPRISE FINANCIAL INC

Holdings History for Sage Therapeutics, Inc. - COM (SAGE)

Symbol: SAGE on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	0%	$1.54M	214K	-60,669	-22.1%	$7.22	Q3 2024
6/30/2024	0%	0%	$2.98M	275K	-84,886	-23.6%	$10.86	Q2 2024
3/31/2024	0%	+0%	$6.74M	360K	+50,800	+16.5%	$18.74	Q1 2024
12/31/2023	0%	0%	$6.69M	309K	-403,689	-56.7%	$21.67	Q4 2023
9/30/2023	0%	0%	$14.7M	712K	-177,619	-20%	$20.58	Q3 2023
6/30/2023	0.01%	0%	$41.8M	890K	-234,775	-20.9%	$47.02	Q2 2023
3/31/2023	0.02%	+0%	$47.2M	1.12M	+41,774	+3.86%	$41.96	Q1 2023
12/31/2022	0.01%	0%	$41.3M	1.08M	-10,433	-0.95%	$38.14	Q4 2022
9/30/2022	0.02%	+0%	$42.8M	1.09M	+321,121	+41.6%	$39.16	Q3 2022
6/30/2022	0.01%	0%	$24.9M	772K	-43,265	-5.3%	$32.30	Q2 2022
3/31/2022	0.01%	+0%	$27M	816K	+37,299	+4.79%	$33.10	Q1 2022
12/31/2021	0.01%	+0%	$33.1M	778K	+91,290	+13.3%	$42.54	Q4 2021
9/30/2021	0.01%	+0%	$30.4M	687K	+82,091	+13.6%	$44.30	Q3 2021
6/30/2021	0.01%	+0%	$34.4M	605K	+157,987	+35.3%	$56.79	Q2 2021
3/31/2021	0.01%	+0%	$33.5M	447K	+57,320	+14.7%	$74.85	Q1 2021
12/31/2020	0.01%	0%	$33.7M	390K	-362	-0.09%	$86.51	Q4 2020
9/30/2020	0.01%	+0%	$23.8M	390K	+17,380	+4.66%	$61.10	Q3 2020
6/30/2020	0.01%	0%	$15.5M	373K	-236,097	-38.8%	$41.59	Q2 2020
3/31/2020	0.01%	+0%	$17.4M	609K	+268,806	+79.1%	$28.66	Q1 2020
12/31/2019			$1K	18			$55.56^*	Q4 2019
12/31/2019	0.01%	0%	$24.5M	340K	-114,928	-25.3%	$72.11	Q4 2019
9/30/2019	0.03%	0%	$63.8M	455K	-9,788	-2.11%	$140.30	Q3 2019
6/30/2019	0.04%	+0.01%	$85.1M	465K	+107,145	+30%	$183.08	Q2 2019
3/31/2019			$1K	5			$200.00^*	Q1 2019
3/31/2019	0.03%	+0.01%	$56.9M	357K	+105,729	+42%	$159.05	Q1 2019
12/31/2018	0.01%	0%	$24.1M	252K	-78,083	-23.7%	$95.78	Q4 2018
9/30/2018			$1K	5			$200.00^*	Q3 2018
9/30/2018	0.02%	0%	$46.3M	330K	-30,109	-8.36%	$140.35	Q3 2018
6/30/2018	0.02%	+0%	$56.3M	360K	+52,626	+17.1%	$156.50	Q2 2018
3/31/2018	0.02%	+0.01%	$49.5M	307K	+128,208	+71.6%	$161.02	Q1 2018
12/31/2017	0.01%	+0.01%	$29.5M	179K	+116,322	+185%	$164.72	Q4 2017
9/30/2017	0%	+0%	$3.91M	62.8K	+3,449	+5.81%	$62.32	Q3 2017
6/30/2017	0%	+0%	$4.72M	59.3K	+552	+0.94%	$79.60	Q2 2017
3/31/2017	0%	0%	$4.18M	58.8K	-458	-0.77%	$71.06	Q1 2017
12/31/2016	0%	0%	$3.02M	59.2K	-16,222	-21.5%	$51.04	Q4 2016
9/30/2016	0%	+0%	$3.48M	75.5K	+17,372	+29.9%	$46.05	Q3 2016
6/30/2016	0%	+0%	$1.75M	58.1K	+45,260	+353%	$30.12	Q2 2016
3/31/2016	0%	+0%	$411K	12.8K	+1,775	+16.1%	$32.03	Q1 2016
12/31/2015			$1K	9			$111.11^*	Q4 2015
12/31/2015	0%	0%	$645K	11.1K	-25,254	-69.5%	$58.33	Q4 2015
9/30/2015	0%	0%	$1.54M	36.3K	-1,417	-3.76%	$42.36	Q3 2015
6/30/2015	0%	+0%	$2.75M	37.7K	+22,798	+153%	$73.00	Q2 2015
3/31/2015	0%	+0%	$750K	14.9K	+14,930	NEW	$50.23	Q1 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.